191 related articles for article (PubMed ID: 11285156)
21. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
22. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
[TBL] [Abstract][Full Text] [Related]
23. [Seroprevalence of markers of transfusion transmissible infections in blood bank in Colombia].
Bedoya JA; Cortés Márquez MM; Cardona Arias JA
Rev Saude Publica; 2012 Dec; 46(6):950-9. PubMed ID: 23503536
[TBL] [Abstract][Full Text] [Related]
24. [Report of the Robert Koch Institute according to Article 22 of the Transfusion Act for the years 2001 and 2002].
Offergeld R; Ritter S; Faensen D; Hamouda O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Dec; 47(12):1216-29. PubMed ID: 15583893
[TBL] [Abstract][Full Text] [Related]
25. Transfusion-transmitted diseases: current problems and challenges.
Bove JR
Prog Hematol; 1986; 14():123-47. PubMed ID: 3003795
[No Abstract] [Full Text] [Related]
26. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of viral hepatitis in Taiwanese male conscriptees with tattoos.
Shi MD; Lee SY; Lee YB
Mil Med; 2007 May; 172(5):539-40. PubMed ID: 17521106
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013.
Keshvari M; Sharafi H; Alavian SM; Mehrabadi H; Zolfaghari S
Transfus Apher Sci; 2015 Aug; 53(1):38-47. PubMed ID: 25892591
[TBL] [Abstract][Full Text] [Related]
29. The safety of blood components and derivatives.
Julius C; Westphal RG
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
[TBL] [Abstract][Full Text] [Related]
30. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
[No Abstract] [Full Text] [Related]
31. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia.
Ben Jemia R; Gouider E
Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983
[TBL] [Abstract][Full Text] [Related]
32. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa.
Nagalo BM; Bisseye C; Sanou M; Kienou K; Nebié YK; Kiba A; Dahourou H; Ouattara S; Nikiema JB; Moret R; Zongo JD; Simpore J
Trop Med Int Health; 2012 Feb; 17(2):247-53. PubMed ID: 21988100
[TBL] [Abstract][Full Text] [Related]
34. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
35. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Seed CR; Kiely P; Keller AJ
Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
Dwyre DM; Fernando LP; Holland PV
Vox Sang; 2011 Jan; 100(1):92-8. PubMed ID: 21175659
[TBL] [Abstract][Full Text] [Related]
37. [Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaoundé Central Hospital in the centre region of Cameroon].
Ankouane F; Noah Noah D; Atangana MM; Kamgaing Simo R; Guekam PR; Biwolé Sida M
Transfus Clin Biol; 2016 May; 23(2):72-7. PubMed ID: 26791918
[TBL] [Abstract][Full Text] [Related]
38. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.
Roth WK; Weber M; Seifried E
Lancet; 1999 Jan; 353(9150):359-63. PubMed ID: 9950441
[TBL] [Abstract][Full Text] [Related]
39. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status.
Haley RW; Fischer RP
Medicine (Baltimore); 2001 Mar; 80(2):134-51. PubMed ID: 11307589
[TBL] [Abstract][Full Text] [Related]
40. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
Weusten JJ; van Drimmelen HA; Lelie PN
Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
